NEW YORK (GenomeWeb News) – BG Medicine today reported a 175 percent increase year over year in revenues for the fourth quarter as product revenues increased more than three-fold.

The Waltham, Mass.-based firm said that revenues for the three months ended Dec. 31, 2012 totaled $1.1 million, up from $379,000 a year ago and beating the average analyst estimate of $940,000. Product revenues increased to $978,000 from $307,000 a year ago, and service revenues rose to $94,000 from $72,000, a 31 percent jump.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genes under positive selection in Plasmodium falciparum populations, genetic variation in Epstein-Barr viruses, and more.

Cancer clinical trial patients settle with Anil Potti and Duke University.

A trio of researchers is trying to raise money to sequence and analyze the genome of a cat with a suite of unusual traits.

Two Johns Hopkins researchers discuss the need for evidence-based data analysis.